Aspira Women's Health Inc. 10-Q filing
Filed 2026-05-15 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0000926617-26-000033
- Form type
- 10-Q
- CIK
- 0000926617
- Primary document
- https://www.sec.gov/Archives/edgar/data/926617/000092661726000033/awhl-20260331x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aspira Women's Health Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $2.0M | - | - |
| Cost Of Revenue | $896,000 | - | - |
| Gross Profit | $1.1M | - | - |
| Operating Income | $-2.2M | - | - |
| Net Income | $676,000 | - | - |
| Eps Basic | 0.02 | - | - |
| Eps Diluted | -0.05 | - | - |
| Cash And Equivalents | $1.3M | - | - |
| Total Assets | $5.1M | - | - |
| Total Liabilities | $11.3M | - | - |
| Shareholders Equity | $-6.2M | - | - |
| Operating Cash Flow | $-359,000 | - | - |